LCLarry W. Chambers

Larry W. Chambers

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Larry W. Chambers has a total of 42 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Culturally sensitive CLEAR guidelines on disclosing and communicating a diagnosis of dementia

    by Zahinoor Ismail, Saskia Sivananthan, Sarah Main, Alixe Ménard, Jhnelle McLaren‐Beato, Larry W. Chambers, Vivian Welch, Isabelle Vedel, Eric E. Smith, Vivian Ewa, et al.

    Providing a dementia diagnosis is challenging, especially in primary care and considering diverse patient backgrounds. The Alzheimer Society of Canada (ASC), the College of Family Physicians of Canada, and the Canadian Consensus Conference on the Diagnosis and Treatment of Dementia (CCCDTD) guideline group partnered with patients, care partners, and clinicians to generate contemporaneous guidance for primary care practitioners. While relevant to all communities, Black and Chinese Canadians were formally represented in working groups. A literature review identified needs areas. Informed by Guidelines International Network (GIN) principles and through iterative group meetings with all partners, these needs were explored and incorporated into guidance. The Compassionate Language and Empathetic Approaches for Respectful Dementia Disclosure (CLEAR) offers recommendations on: holistic engagement, fostering hope, acknowledging care partners, identifying disclosing clinicians, appointment structure and environment, person‐centered communication, specific discussion topics, and emotional supports, all through a cultural competence lens. These guidelines address communication challenges in disclosing a dementia diagnosis and enhancing care and support for persons living with dementia and their care partners. Highlights: Healthcare practitioners (HCPs) struggle with disclosing and communicating dementia diagnoses. Guidance is limited in primary care and different patient ethnocultural groups. We developed culturally sensitive guidelines with scripts and practical materials. Appropriate communication techniques and terminology are recommended in Compassionate Language and Empathetic Approaches for Respectful Dementia Disclosure (CLEAR). Patient‐centered and holistic approaches for the patient and care partner are emphasized.


  • Open Access

    Toward compassionate communication: a rapid review on facilitating the dementia disclosure process

    by Alixe Ménard, Emily Clark, Leah Hagerman, Maureen Dobbins, Eric E. Smith, Isabelle Vedel, Larry W. Chambers, Ngozi Iroanyah, Sobhneek Hothi, Saskia Sivananthan, et al.

    Individuals with dementia and their care partners often report dissatisfaction with the disclosure process due to insufficient information and support. Healthcare providers face challenges in effective communication and connecting patients to post‐diagnostic resources. To address these issues and emphasize person‐centered communication, especially in diverse communities, we conducted a rapid systematic review consolidating preferences for dementia diagnosis disclosure from patients, care partners, and healthcare providers. Searches across MEDLINE, PsycInfo, Emcare (January 2013–February 2023), and gray literature identified 21 relevant articles, including those focusing on Black and Chinese populations. Four themes emerged: (1) setting up appointments, (2) appointment content, (3) overall approach, and (4) cultural competence in dementia disclosure. The Setting, Perception, Invitation, Knowledge, Emotions, and Strategy/Summary (SPIKES)‐D tool was noted but lacked real‐world evaluations and cultural applicability. Our review highlights the need for tailored tools and standardized guidelines, particularly for culturally competent dementia disclosure practices.Highlights: More than 50% of individuals globally express dissatisfaction with dementia diagnosis disclosure. Primary care providers face significant challenges in communicating dementia diagnoses effectively. Adoption of person‐centered approaches is critical in improving dementia disclosure practices.


  • Open Access

    Dementia prevention needs funding

    by Larry W Chambers, Charles Alessi, Muir Gray


  • Open Access

    Guide to enable health charities to increase recruitment to clinical trials on dementia

    by Larry W. Chambers, Megan Harris, Elizabeth Lusk, Debbie Benczkowski

    Introduction: The Alzheimer Society embarked on a project to improve ways that the 60 provincial and local Societies in Canada can work with local researchers to support recruitment of volunteers to clinical trials and studies. A Guide to assist these offices was produced to design ethical recruitment of research volunteers within their client populations. Methods: Consultations with individuals from provincial and local Societies, as well as researchers and leaders from health‐related organizations, were conducted to identify in what ways these organizations are involved in study volunteer recruitment, what is and is not working, and what would be helpful to support future efforts. The Guide prototype used scenarios to illustrate study volunteer recruitment practices as they have been or could be applied in Societies. An implementable version of the Guide was produced with input from multiple internal and external reviewers including subject‐matter experts and target users from Societies. Results: Society staff reported that benefits of using the Guide were that it served as a catalyst for conversation and reflection and identified the need for a policy. Also, it enabled Society readiness to respond to requests by persons with dementia and their caregivers wishing to participate in research. A majority (94%) of participating Society staff across Canada agreed that they would increase their capacity to support research recruitment. Discussion: Charitable organizations that raise funds for research have a role in promoting the recruitment of persons with dementia and their caregivers into clinical trials and studies. The Guide was produced to facilitate organizational change to both create a positive culture regarding research as well as practical solutions that can help organizations achieve this goal.


  • Open Access

    Reducing the confusion and controversies around pragmatic trials: using the Cardiovascular Health Awareness Program (CHAP) trial as an illustrative example

    by on behalf of the CHAP investigators, Lehana Thabane, Janusz Kaczorowski, Lisa Dolovich, Larry W. Chambers, Lawrence Mbuagbaw

    Knowledge translation (KT) involves implementation of evidence-based strategies and guidelines into practice to improve the process of care and health outcomes for patients. Findings from pragmatic trials may be used in KT to provide patients, healthcare providers and policymakers with information to optimize healthcare decisions based on how a given strategy or intervention performs under the real world conditions. However, pragmatic trials have been criticized for having the following problems: i) high rates of loss to follow-up; ii) nonadherence to study intervention; iii) unblinded treatment and patient self-assessment, which can potentially create bias; iv) being less perfect experiments than efficacy trials; v) sacrificing internal validity to achieve generalizability; and vi) often requiring large sample sizes to detect small treatment effects in heterogeneous populations. In this paper, we discuss whether these criticisms hold merit, or if they are simply driven by confusion about the purpose of pragmatic trials. We use the Cardiovascular Health Awareness Program (CHAP) trial - a community randomized pragmatic trial designed to assess whether offering a highly organized, community-based CHAP intervention compared to usual care can reduce cardiovascular disease-related outcomes - to address these specific criticisms and illustrate how to reduce this confusion. Current controlled trials ISRCTN50550004 (9 May 2007).


  • Open Access

    The impact of a cardiovascular health awareness program (CHAP) on reducing blood pressure: a prospective cohort study

    by Chenglin Ye, Gary Foster, Janusz Kaczorowski, Larry W Chambers, Ricardo Angeles, Francine Marzanek-Lefebvre, Stephanie Laryea, Lehana Thabane, Lisa Dolovich

    Background: Hypertension is an important and modifiable cardiovascular risk factor that remains under-detected and under-treated, especially in the older individuals. Community-led interventions that integrate primary health care and local resources are promising approaches to improve awareness and management of hypertension and other cardiovascular risk factors. We aimed to evaluate the effect of a community-based Cardiovascular Health Awareness Program (CHAP) on participants’ blood pressure. Methods: This study followed a cohort of community residents that participated in CHAP across 22 mid-sized Ontario communities over an 18-month period. The participants’ baseline risk factors, including blood pressure, and subsequent measures of blood pressure were recorded. We employed a bivariate linear mixed-effect model to estimate the change of systolic and diastolic blood pressure over time among the participants who attended more than two CHAP sessions. Results: Of 13,596 participants, 2498 attended more than two CHAP sessions. For those repeated participants (attending more than two sessions) initially identified with high blood pressure, the average reduction of systolic blood pressure was from 142 to 123 mmHg over an 18-month period, a monthly rate ratio of 0.992 (95% CI: 0.991,0.994; p < 0.01). Similarly, the average reduction of diastolic blood pressure was from 78 to 69 mmHg, a monthly rate ratio of 0.993 (95% CI: 0.991,0.994; p < 0.01). The average blood pressure of the participants with normal baseline blood pressure remained controlled and unchanged. We also found that older adult participants who lived alone, were diagnosed with hypertension, reported healthier eating habits, and presented with a higher baseline systolic blood pressure had significantly greater odds of attending more than one session. Conclusions: CHAP was associated with a reduction in systolic and diastolic blood pressure for those participants who attended more than one session. The magnitude of blood pressure reductions was significant clinically and statistically.


  • Open Access

    Comparison of blood pressure measurements using an automated blood pressure device in community pharmacies and family physicians' offices: a randomized controlled trial

    by Larry W. Chambers, Janusz Kaczorowski, Susan O’rielly, Sandra Ignagni, Stephen J.C. Hearps

    Background Accurate measurement of blood pressure is the foundation of appropriate diagnosis, treatment and ongoing management of hypertension. The use of automated blood pressure devices in community settings such as pharmacies provide opportunities for additional blood pressure measurement; however, it is important to ensure that these measurements are comparable to those taken in physicians’ offices using the same devices. We conducted a randomized controlled trial to assess whether blood pressure readings assessed by use of an automated device differed according to the setting, specifically in community pharmacies and family physicians’ offices. Methods We included adults aged 65 years and older who did not live in long-term care facilities or in hospital. The trial was administered by volunteer peer health educators, family physicians and pharmacists in 2 midsized communities in Ontario from April to September 2010. The 5 participating family physicians mailed invitations to their eligible patients. Those who gave informed consent were randomly allocated to 1 of 2 assessment sequences: group A had their blood pressure measured at their physician’s office, then at a pharmacy, then again at their physician’s office; those in group B had their blood pressure measured at a pharmacy, then at their physician’s office, then again at a pharmacy. An automated blood pressure device (BpTRU) was used in both settings. We calculated the differences in mean systolic and diastolic blood pressure, and we compared the readings at both settings and by sequence of assessment. Results In total, 275 adults completed the trial (mean age 75.9 yr, 49.5% male, 46.9% with a self-reported diagnosis of hypertension). There were no statistically significant differences in systolic or diastolic blood pressure measurements associated with the sequence of assessment or the setting. There was a significant difference in the overall mean systolic blood pressure between the 2 assessment sequences (group A 122.0 v. group B 127.8 mm Hg, p < 0.001). Interpretation Automated devices used in pharmacies to measure blood pressure provide accurate and valid information that can be used in the diagnosis and management of hypertension among older adults in the community. Trial registration: www.controlled-trials.com, no. ISRCTN91799042.


  • Seasonal influenza vaccination campaigns for health care personnel: systematic review

    by P.-P. Lam, Larry W. Chambers, Donna M. Pierrynowski MacDougall, Anne E. McCarthy

    Background: In Canada, vaccination coverage for seasonal influenza among health care personnel remains below 50%. The objective of this review was to determine which seasonal influenza vaccination campaign or campaign components in health care settings were significantly associated with increases in influenza vaccination among staff. Methods: We identified articles in eight electronic databases and included randomized controlled trials, controlled before-and-after studies and studies with interrupted time series designs in our review. Two reviewers independently abstracted the data and assessed the risk of biases. We calculated risk ratios and 95% confidence intervals for randomized controlled trials and controlled before-and-after studies and described interrupted time series studies. Results: We identified 99 studies evaluating influenza vaccination campaigns for health care workers, but only 12 of the studies were eligible for review. In nonhospital health care settings, including long-term care facilities, campaigns with a greater variety of components (including education or promotion, better access to vaccines, legislation or regulation and/or role models) were associated with higher risk ratios (i.e, favouring the intervention group). Within hospital settings, the results reported for various types of campaigns were mixed. Many of the criteria for assessing risk of bias were not reported. Interpretation: Campaigns involving only education or promotion resulted in minimal changes in vaccination rates. Further studies are needed to determine the appropriate components and combinations of components in influenza vaccination campaigns for health care personnel.